ABSTRACT-We examined the protective activity of fructose l,6-bisphosphate (FBP) on mortality and delayed hippocampal cell death induced by transient cerebral ischemia in the Mongolian gerbil. Forebrain ischemia was produced by bilaterally occluding the common carotid arteries for 15 min using micro aneurysm clips; then the blood supply to the brain was restored. The number of survivors was counted for 8 days, and the histopathological damage in the CAI region of the hippocampus was scored according to the semiquantitative scale of Rudolphi and colleagues. When injected 15 min before the ischemic insult, FBP (100 and 333 mg/kg, i.v.) significantly reduced the rate of mortality during the 8-day observation period. Equivalent doses of fructose and fructose monophosphate did not improve survival, and neither did low doses (33 mg/kg) of FBP. FBP also produced a significant degree of protection against the CAI pyramidal cell loss in comparison with its vehicle (distilled water). Conversely, when we administered the compound, at the same dose, 15 min after the release of the arterial occlusion, we observed neither a significant reduc tion of mortality nor significant protection against hippocampal CAI pyramidal cell loss. These results sug gest that FBP possesses salutary properties against the damages induced by transient cerebral ischemia, although they are evident only when the compound is administered before the resolution of the ischemic injury.
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Keywords: Cerebral ischemia (transient, gerbil), Neuronal death (delayed), Fructose 1,6-bisphosphate Fructose-1,6-bisphosphate (FBP), a high energy inter mediate of glycolysis, has been shown to exert a protec tive action against the ischemia-induced damage to a vari ety of different tissues. It has been reported to reduce the tissue damage associated with cardiac arrest (1), myocar dial ischemia (2) and myocardial infarct (3). Didlake and colleagues (4) observed a substantial prevention of the ischemic renal injury in rats treated with FBP. It has also been reported to reduce mortality in dogs subjected to bilateral hind limb tourniquet ischemia (5) and to prevent tissue damage and death in rats with an occlusion of the superior mesenteric artery followed by recirculation (6) . In addition, FBP seems to exert a significant protective action in a variety of shock states, reducing mortality and attenuating organ damage (7 10) . Recently, Gregory and colleagues (11) described a protective effect possessed by FBP in combination with glucose against hypoxic injury on primary cultures of cortical astrocytes. FBP was also demonstrated to possess salutary properties in an ex perimental in vivo model of ischemic/hypoxic brain in jury in the rabbit (12) . Bearing in mind that following a transient interruption of the blood flow to the forebrain, a selective neuronal death is observed in the hippocampus and, in particular, that this damage presents a particularly slow develop ment, being evident several days after the resolution of the ischemic insult (13), we designed the present series of experiments to investigate whether treatment with FBP can ameliorate the delayed damages induced by forebrain ischemia followed by recirculation. In particular, we evalu ated the eventual beneficial effects of the compound on the rate of survival and on the delayed death of neurons in the CAI region of the hippocampus, which is known to be a region of selective ischemic vulnerability. We con ducted the experiments in the Mongolian gerbil, a rodent in which, due to an unusual cerebral circulation, the bilateral occlusion of common carotid arteries provides a simple and reproducible model of cerebral ischemia. gauge needle the dorsal vein of the penis. Fifteen minutes after drug or vehicle administration, an anterior midline cervical incision was made, and both common carotid arteries were exposed and isolated from the vagus nerve. Two microaneurysm clips were placed on them so that the blood flow was completely arrested. The blood flow was interrupted for 15 min, and then the blood was allowed to recirculate in the brain by removing the clips. The patency of the carotid arteries was checked by direct visualization, the skin incision was then sutured and the animals placed in single cages. The second group of animals received the same surgical treatment but was given 333 mg/kg of FBP 15 min after the release of the carotid artery occlusion (post-ischemic treatment). The sham operation group con sisted of gerbils that underwent all the surgical procedures described above with the exception of artery occlusion. Care was taken to keep the rectal temperature in all animals not below 371C throughout the surgical proce dures and until the recovery from the anesthesia. Animals were kept in single cages and placed in a quiet room for 24 hr in order to avoid post-ischemic seizures triggered by noise. Thereafter, they were transferred to standard cages, with 4 animals in a cage, and unlimited food and water. Animals were continuously observed for 12 hr after recirculation, and then the number of deaths was taken twice a day (9 AM and 6 PM) for 8 days. On day 9, the animals were anesthetized with chloral hydrate (380 mg/kg) and perfused transcardially with 13.3 % formalde hyde in 0.15 M NaCl solution. The brains were removed from the skull and placed in 13.3% formaldehyde and maintained at 41C until the day of processing. At that time, they were rinsed in tap water for 3 hr and then dehy drated with a series of ethanol solutions (from 30°10 to 10010). The dehydrated samples were placed in xylene for 1 hr and then for 30 min in 50% xylene in paraffin 1 at 37 391C. Samples were maintained for 12 hr in paraffin I and then for a further 12 hr in paraffin 2. Slices contain ing the hippocampus (7,u thick) were cut using a micro tome and slide-mounted prior to staining with Cresyl violet. The histological analysis was done independently by two of us unaware of the treatment received by the animal, and the results were scored using the scale of Rudolphi et al. (14): 0=no cell necrosis, 1=few single cell necrosis, 2 =areas of necrotic cells, 3 =most cells necrotic, 4=no intact cells.
MATERIALS AND METHODS

Adult
We determined the histological damage 8 days after recirculation because in a pilot study, we had previously tested the effects of the transient interruption of the carotid blood supply to the brain at different time-points after recirculation. In this experiment, gerbils that under went the same experimental procedures described above but did not received any treatment were sacrificed 2, 4 and 8 days after the release of the carotid occlusion, and the pyramidal cell loss in the CAI subfield of the hippocam pus was evaluated using the same protocol previously described.
Survival rates were compared by the Kruskal-Wallis test, whereas the nonparametric Wilcoxon Rank Sum test (independent samples) was used to analyze histopathologi cal data. A probability of less than 0.05 was considered to indicate a significant difference.
RESULTS
The effects of FBP on mortality during the cerebral blood flow interruption Sham operation produced no mortality in 16 gerbils within the 8-day observation period. During the 15 min of cerebral blood flow interruption, two gerbils out of 20 in the vehicle-treated group and 6 out of 38 in the group with no treatment (animals which will receive FBP or its vehicle at the release of the occlusion) died, showing clear respiratory problems (Fig. 1 and Table 1 ). Two gerbils in the group treated with 33 mg/kg (N= 12) died, while all the animals administered with FBP at the dose of 100 and 333 mg/kg survived during the 15 min cerebral blood flow interruption (Fig. 1) . All gerbils that received 1 g/kg of FBP (N = 8) died either during the ischemic period (six) or within 45 min after recirculation (two). Moreover, this dose of FBP also produced effects in some way toxic, such as sedation and a marked loss in body weight, in the sham-operated animals, and five gerbils out of eight died within 24 hr after the injection. Thus, we did not further use the dose of 1 g/kg of FBP.
The effects of FBP administered before the ischemia on mortality and hippocampal cell death during recirculation
In the vehicle pretreatment group, five out of the eigh teen gerbils that survived during the ischemic period died within 48 hr from the release of the occlusion; and by the eighth day, only 9 animals were still alive (Fig. 1) . Pretreatment with FBP resulted in a reduction of the mor tality and protection of hippocampal CAI neurons. In fact, no deaths were detected in gerbils that received 333 mg/kg of FBP 15 min before the ischemic insult up to 5 days from the release of the occlusion. Sixteen animals out of 20, however, showed a monolateral ptosis. On the sixth day of recirculation, two animals out of 20 died, whereas the survivors showed a visible loss of fur; and by the eighth day, only 15 animals were alive. Analyzing these data by means of the Kruskal-Wallis test, we found a highly significant (Z=0.00096) enhancement of the sur vival rate in the FBP-treated group as compared to that in the vehicle-treated one. At the dose of 100 mg/kg, FBP also showed a beneficial effect in comparison to its vehicle in reducing mortality, although it appeared to be of a much lower extent (Z=0.032) in comparison with the higher dose. Conversely, no protection was observed when the compound was administered at the dose of 33 mg/kg (Fig. 1) . Table 1 . Effect of fructose-l,6-bisphosphate (FBP) given post ischemically on the number of survivors after 15 min of forebrain ischemia followed by recirculation in the Mongolian gerbil The effects of the treatment with FBP (100 and 333 mg/kg, i.v.) 15 min before the cerebral blood flow inter ruption on the neuronal death in the CAI region of the hippocampus evaluated 8 days after recirculation are presented in Figs. 2 and 3 . Table 2 presents the changes of the overall histological alterations of the different animal groups by using the total scores (sum of individual scores/number). A transient interruption of the carotid blood flow produces profound damages to the pyramidal cells of the CAI subfield of the hippocampus (Fig. 3) . Following 15 min of forebrain ischemia, 87.5% of the animals that intravenously received distilled water showed a total pyramidal cell loss. This effect was evident 8 days after the ischemic insult, whereas it was not observ able 2 days after. When we sacrificed the gerbils 4 days after recirculation, however, we observed a total score of 2.5. In fact, in this group, 3 out of 8 gerbils received a score of 4, 3 received a score of 2, and 2 were graded as 1 in the Rudolphi's histological scale. Fig. 3 . Micrograph of the hippocampus CAI-subfield of a sham-operated animal (A) and a gerbil that underwent a 15 min common artery occlusion followed by 8 days recirculation and was intravenously treated with distilled water 15 min before the forebrain blood flow interruption (B) and a gerbil subjected to the same surgical procedures but treated with 333 mg/kg of fruc tose-l,6-bisphosphate (C). Note that sample A was given the score of 0, B the score of 4 and C was graded as 2 according to the semiquantitative histopathological score described in the Method section. Cresyl violet.
Intravenous pretreatment with FBP at the dose of 333 mg/kg showed protecting properties against the delayed death of pyramidal cells in the hippocampus; in fact, the percentage of animals showing grade 4 or 3 of histological damage, according to the semiquantitative score used (14) , was significantly (P = 0.0206) reduced in comparison to the vehicle-treated animals. However, at the dose of 100 mg/kg, the compound did not elicit any statistically significant (P=0.234) protection (Fig. 2 and Table 2 ). To investigate if fructose or fructose monophosphate also shares with FBP the capability of reducing mortality during recirculation after an ischemic insult of the brain, we administered the two compounds at the dose of 148 and 249 mg/kg, respectively, 15 min before the blood flow interruption by the same route as used for FBP. No significant differences were detected in the survival rate in the animals that received fructose or fructose monophos phate 15 min before the ischemic insult as compared to the animals that received distilled water (Fig. 4) .
The effects of FBP administered after the release of the carotid artery occlusion Up to 2 days from the release of the occlusion, we did not observe any deaths of the animals that received FBP (333 mg/kg) post-ischemically. However, by the eighth day, only 42.1 % of the gerbils were still alive either in the FBP-group or in the vehicle-treatment group (Table 1) . Moreover, FBP elicited no statistically significant protec tive effects against the ischemia-induced hippocampal neuronal loss as indicated in Fig. 5 . beneficial effect against mortality and degeneration of hip pocampal CAI pyramidal neurons following transient forebrain ischemia. In fact, gerbils treated with 333 mg/kg of FBP 15 min before the ischemic insult to the brain elicited an enhanced rate of survival and a sig nificant reduction in the severity of delayed neuronal loss with respect to animals treated with its vehicle. In contrast, the administration of fructose or fructose monophosphate, at a dose molarly equivalent to 333 mg/kg of FBP, did not produce any significant improve ment in survival in this model of cerebral ischemia. Fruc tose-l,6-bisphosphate, however, demonstrated salutary properties also when given at a dose of 100 mg/kg, but only in reducing mortality, whereas it was not effective in protecting from delayed neuronal loss in the CAI subfield of the hippocampus. According to this, we should rule out any relation between mortality and delayed pyramidal cell death, although it should be considered that the treat ment with FBP at the dose of 100 mg/kg significantly modified the shape of the survival curve (Fig. 1) , reducing mortality during the ischemic period and the earlier phase of recirculation, but exerting only a modest protection against the overall mortality after 8 days of recirculation (i.e., when the histological damage was quantified). All these results appear to agree with some previous observa tions (11, 12, 15, 16) . When comparing, however, the results of the present study with others, a couple of fac tors should be considered. Farias and colleagues (12) reported that in a rabbit model of cerebral ische mia/hypoxia, a bolus injection of 350 mg/kg of FBP fol lowed by a constant infusion for 90 min was able to pro tect the animals against mortality, changes in EEG and histological damage. In their model, Farias and col leagues administered the compound during the blood flow interruption and continued the infusion after recircu lation. Gregory and colleagues (11) , on the other hand, observed that FBP exerted its protective effect in cultured rat astrocytes subjected to hypoxia only when it was as sociated with glucose. It should also be noted that FBP was already present in the medium when hypoxia was ini tiated. Moreover, when we injected FBP after recircula tion, we detected protective effects against neither mortal ity nor histological damage. Therefore, although the differences in the experimental models make any compari son difficult, it could be speculated that in order to elicit beneficial effects, FBP has to be administered before the restoration of cerebral blood supply. The salutary effects shown by FBP might be explained considering that ischemia produces a depletion of the brain stores of ATP; and by reducing either aerobic or anaerobic metabolism, FBP might have increased ATP production throughout the glycolitic pathway as soon as recirculation has been allowed. In support of this hypo thesis, data showing the ability of FBP to increase ATP levels during ischemia or hypoperfusion in several differ ent tissues exist (2, 5) . The understanding of the mecha nisms by which FBP modifies ATP levels is, however, a difficult task. FBP could enter the cell, bypass the reac tion involving phosphofructokinase and increase ATP production (5). Phosphofructokinase represents a key enzyme in glycolysis that appears to be inhibited by hypoxia. However, this mechanism presupposes that exogenous FBP enters the cell, whereas only indirect evidence support this possibility (4) . Conversely, studies based on [14C]FBP uptake in erythrocytes demonstrated that the compound does not enter the cell (17, 18) . Fur thermore, no evidence has been provided until now that FBP is taken up by brain cells, although recently, in an experiment conducted on isolated cortical astrocytes in vitro, a rapid incorporation of FBP into cells has been reported (11) . Moreover, this phenomenon seems to be energy-dependent since it decreased by nearly 70076 when the temperature was reduced from 37 to 01C. Farias and colleagues (12) , in their attempt to explain the beneficial effects of FBP, theorized that FBP has the ability to pre vent the generation of oxygen free radicals, which are known to play a role in the pathogenesis of ischemia/recir culation injury. During arterial occlusion, the depressed mitochondrial activity is accompanied by an enhance ment of ATP dephosphorylation; this elevates the AMP concentration within the cell. The AMP accumulated is, in turn, metabolized to adenosine and hypoxanthine (19, 20) . When recirculation is allowed, hypoxanthine is con verted to xanthine by the enzyme xanthine oxidase, and this reaction generates oxygen free radicals (21) . It could be speculated that FBP decreases the generation of free radicals by attenuating the depletion of high-energy adenylnucleotides and their degradation to hypoxan thine. This could also explain why only a pre-ischemic treatment with FBP is effective. Although the role of xan thine oxidase as a major source of free radicals in focal cerebral ischemia has been recently questioned (22) , this hypothesis could represent the basis for further investiga tions.
Another mechanism that should be considered when trying to explain the pharmacological activity of FBP is that the ATP depletion during the blood flow interrup tion period produces a failure of ATP-dependent ionic pumps which, in turn, results in an accumulation of sodium, calcium and chloride into the cell, accompanied by a rapid loss of potassium (23) . Calcium, in particular, is recognized to play a pivotal role in the pathophysiology of stroke. One of the postulated consequences of calcium influx is the activation of phospholipase C resulting in the breakdown of phospholipids in the cell membrane and liberation of free fatty acids (24) . In particular, arachidon ic acid seems to increase in neurons in direct correlation with the duration of the ischemic period (25) , and this phenomenon appears to be more marked in brain regions known to be particularly sensitive to ischemia/recircula tion-induced injury (26) . Arachidonic acid is known to produce edema (27) , to cause changes in the release and uptake of neurotransmitters such as glutamate and GABA (28, 29) and, once oxygen is again provided by recirculation, is metabolized to prostaglandins, throm boxanes (30, 31) and superoxide (32) .
These and other possible mechanisms, such as the reduction of the activation of polymorphonuclear leuco cytes entrapped in the cerebral vessels, which may result in the production of chemotactic factors during recircula tion (33 35) , represents only a speculative attempt to ex plain the observed effects of the compound and have to be taken as a working hypothesis to initiate investigations into the mode of action of FBP which still must be clarified through intense studies. Indeed, FBP allows ger bils to better tolerate surgery. In fact, no animals died dur ing the surgical procedures when treated with 100 and 333 mg/kg of the compound. On the other hand, in our laboratory, this effect has also been observed in other spe cies and in surgery of different types such as stereotactic surgery in rats (G.R. Trimarchi and R. De Luca, unpub lished observation). Furthermore, FBP, but not fructose or fructose-6-phosphate, when pre-ischemically injected at the dose of 333 mg/kg, was able to reduce the delayed neuronal loss in the CAI subfield of the hippocampus. All these observations, taken together, warrant further in vestigations of this fascinating compound, which certain ly should be pharmacologically characterized through more detailed studies.
